MedTrace Logo

Changing Diabetes in Children

NCT02382757 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3089

Last updated 2015-03-09

No results posted yet for this study

Summary

This study is conducted in Asia. The primary objective of the CDiC programme is to improve access to comprehensive diabetes care among the children with diabetes from the economically underprivileged section of the population and to establish a registry for this group of children with type 1 diabetes in India.

Conditions

Interventions

DRUG

insulin human

Children will receive conventional treatment with human insulin according to standard medical practice.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02382757 on ClinicalTrials.gov